Literature DB >> 24585560

Editorial commentary: Risks and benefits of tenofovir in the context of kidney dysfunction in sub-Saharan Africa.

Michelle M Estrella1, Mohammed R Moosa, Jean B Nachega.   

Abstract

Entities:  

Keywords:  HIV; kidney disease; sub-Saharan Africa; tenofovir

Mesh：

Substances：

Year:  2014        PMID： 24585560      PMCID： PMC4001289          DOI： 10.1093/cid/ciu123

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  16 in total

Review 1.  Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients.

Authors:  Ryan D Cooper; Natasha Wiebe; Nathaniel Smith; Philip Keiser; Saraladevi Naicker; Marcello Tonelli
Journal:  Clin Infect Dis       Date:  2010-09-01       Impact factor: 9.079

2.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Authors:  Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort
Journal:  Lancet       Date:  2010-05-17       Impact factor: 79.321

3.  The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women.

Authors:  Michelle M Estrella; Rulan S Parekh; Alison Abraham; Brad C Astor; Lynda A Szczech; Kathryn Anastos; Jack A Dehovitz; Daniel J Merenstein; C Leigh Pearce; Phyllis C Tien; Mardge H Cohen; Stephen J Gange
Journal:  J Acquir Immune Defic Syndr       Date:  2010-10       Impact factor: 3.731

4.  Antiretroviral therapy in the treatment of HIV-associated nephropathy.

Authors:  Mohamed G Atta; Joel E Gallant; M Hafizur Rahman; Nagapradeep Nagajothi; Lorraine C Racusen; Paul J Scheel; Derek M Fine
Journal:  Nephrol Dial Transplant       Date:  2006-07-24       Impact factor: 5.992

5.  Renal function in patients with preexisting renal disease receiving tenofovir-containing highly active antiretroviral therapy in the HIV outpatient study.

Authors:  Benjamin Young; Kate Buchacz; Anne Moorman; Kathy C Wood; John T Brooks
Journal:  AIDS Patient Care STDS       Date:  2009-08       Impact factor: 5.078

6.  Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia.

Authors:  Lloyd Mulenga; Patrick Musonda; Albert Mwango; Michael J Vinikoor; Mary-Ann Davies; Aggrey Mweemba; Alexandra Calmy; Jeffrey S Stringer; Olivia Keiser; Benjamin H Chi; Gilles Wandeler
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

Review 7.  End-stage renal disease in sub-Saharan and South Africa.

Authors:  Saraladevi Naicker
Journal:  Kidney Int Suppl       Date:  2003-02       Impact factor: 10.545

8.  Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.

Authors:  Andrew Reid; Wolfgang Stöhr; A Sarah Walker; Ian G Williams; Cissy Kityo; Peter Hughes; Andrew Kambugu; Charles F Gilks; Peter Mugyenyi; Paula Munderi; James Hakim; Diana M Gibb
Journal:  Clin Infect Dis       Date:  2008-04-15       Impact factor: 9.079

9.  Observations on a cohort of HIV-infected patients undergoing native renal biopsy.

Authors:  Adam R Berliner; Derek M Fine; Gregory M Lucas; M Hafizur Rahman; Lorraine C Racusen; Paul J Scheel; Mohamed G Atta
Journal:  Am J Nephrol       Date:  2008-01-04       Impact factor: 3.754

Review 10.  Chronic kidney disease: effects on the cardiovascular system.

Authors:  Ernesto L Schiffrin; Mark L Lipman; Johannes F E Mann
Journal:  Circulation       Date:  2007-07-03       Impact factor: 29.690
View more
  4 in total

1.  Incidence of stage 3 chronic kidney disease and progression on tenofovir-based regimens.

Authors:  Hadas Zachor; Rhoderick Machekano; Michelle M Estrella; Peter J Veldkamp; Michele D Zeier; Olalekan A Uthman; Jantjie J Taljaard; Mohammed R Moosa; Jean B Nachega
Journal:  AIDS       Date:  2016-05-15       Impact factor: 4.177

2.  Changes in estimated glomerular filtration rate over time in South African HIV-1-infected patients receiving tenofovir: a retrospective cohort study.

Authors:  Reneé De Waal; Karen Cohen; Matthew P Fox; Kathryn Stinson; Gary Maartens; Andrew Boulle; Ehimario U Igumbor; Mary-Ann Davies
Journal:  J Int AIDS Soc       Date:  2017-04-10       Impact factor: 5.396

3.  Longitudinal Progression of Estimated GFR in HIV-1-Infected Patients with Normal Renal Function on Tenofovir-Based Therapy in China.

Authors:  Fang Liu; Aifang Xu; Huaqing Zhao; Zongxing Yang; Chen Chen; Brona Ranieri; Jianfeng Bao; Guoxiang Zheng; Miaochan Wang; Ying Wang; Yunhao Xun
Journal:  Ther Clin Risk Manag       Date:  2020-04-17       Impact factor: 2.423

4.  Factors Associated with Antiretroviral Therapy Toxicity Out-Comes in Patients with and without Hypertension.

Authors:  Sabelo Bonginkosi Dlamini; Ming-Tsang Wu; Hans-Uwe Dahms
Journal:  Int J Environ Res Public Health       Date:  2022-09-03       Impact factor: 4.614
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.